Avaliação da atividade antifúgica de Pterocaulon alopecuroides em amostras de Fonsecaea pedrosol

45

SIXTEEN YEARS OF DERMATOMYCOSIS CAUSED BY Candida spp. IN THE METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL

The yeasts of the genus Candida infect skin, nails, and mucous membranes of the gastrointestinal and the genitourinary tract. The aim of this study was to determine the prevalence of dermatomycoses caused by Candida spp., and their etiological aspects in the metropolitan area of Porto Alegre, Brazil. A retrospective study with data obtained from tertiary hospital patients, from 1996 to 2011, was performed. The analyzed parameters were date, age, gender, ethnicity, anatomical region of lesions, and the direct examination results. For all the statistical analyses, a = 0.05 was considered. Among positive results in the direct mycological examination, 12.5% of the total of 4,815 cases were positive for Candida spp. The angular coefficient (B) was -0.7%/ year, showing a decrease over the years. The genus Candida was more prevalent in women (15.9% of women versus 5.84% of men), and in addition, women were older than men (54 versus 47 years old, respectively). There was no difference between ethnic groups. The nails were more affected than the skin, with 80.37% of the infections in the nails (72.9% in fingernails and 7.47% in toenails). Our study corroborates the literature regarding the preference for gender, age, and place of injury. Moreover, we found a decrease in infection over the studied period

Avaliação do perfil proteolítico de amostras de Sporothrix schenckii

44

Perfil lipídico e atividade antimicrobiana de óleos microbianos de 16 leveduras oleaginosas isoladas de queijo artesanal

Microbial oil is becoming an alternative to the increasing cost of vegetable oils, and it can be used for many applications, as biodiesel production and food supplementation. In particular, oleaginous yeasts, being unicellular, devoid of endotoxins, and suitable for large-scale fermentation, are particularly attractive for biotechnological approaches. This work aimed to identify, by molecular analyses, sixteen yeast strains as well as analyze the lipid profile and potential antimicrobial activity of the oil produced by them. All strains were identified as Yarrowia lipolytica, a promising single-cell-oil producer. No antimicrobial activity was found for the oil analyzed, although the lipid profile showed interesting results. The major fatty acids identified were oleic (18:1n9) and linoleic (18:2n6c) and the minor fatty acids were palmitic (C16:0), palmitoleic (C16:1), heptadecanoic (C17:1), estearic (C18:0) and α-linolenic (C18:3n3). This last omega-3 fatty acid was identified on two strains (QU22 and QU137), enabling the oil produced by them to be used for dietary applications. Moreover, the oil of the other oleaginous yeasts analyzed in this study appears to be suitable for biodiesel production, since their lipid profiles are similar to the vegetable oils, widely used for that end.O uso de óleo microbiano está se tornando uma alternativa ao aumento do custo de óleos vegetais, e podendo ser utilizado para várias aplicações, como a produção de biodiesel e a suplementação de alimentos. Em particular, as leveduras oleaginosas, sendo unicelulares, desprovidas de endotoxinas e adequadas para a fermentação em grande escala, são particularmente atrativas para abordagens biotecnológicas. Este trabalho teve como objetivo identificar, por meio de técnicas moleculares, dezesseis cepas de leveduras e analisar o perfil lipídico e a potencial atividade antimicrobiana do óleo produzido por elas. Todas as cepas foram identificadas como Yarrowia lipolytica, uma promissora produtora de óleo microbiano. Nenhuma atividade antimicrobiana foi encontrada para o óleo analisado, porém, o perfil lipídico dos óleos apresentaram resultados interessantes. Os principais ácidos graxos identificados foram oléico (18:1n9) e linoléico (18:2n6c) e os ácidos graxos em menor quantidade foram o palmítico (C16:0), palmitoléico (C16:1), heptadecanóico (C17:1), esteárico (C18:0) e α -linolênico (C18:3n3). Este último ácido graxo ômega-3 foi identificado em duas cepas (QU22 e QU137), o que pode permitir que o óleo produzido por estas cepas seja utilizado em aplicações alimentares. Além disso, o óleo das demais leveduras oleaginosas analisadas neste estudo parece ser adequado para a produção de biodiesel, uma vez que o seu perfil lipídico é semelhante ao dos óleos vegetais, largamente utilizados para este fim

Identification of Eschweilenol C in derivative of Terminalia fagifolia Mart. and green synthesis of bioactive and biocompatible silver nanoparticles

A green synthetic route was developed to prepare silver nanoparticles (AgNPs) in aqueous solution for biological applications. Eschweilenol C, a compound derivative ellagic acid was identified as the main constituent of the aqueous fraction of the ethanolic extract of Terminalia fagifolia Mart. by NMR analysis. In the green synthesis, the ethanolic extract of T. fagifolia and its aqueous fraction were used to promote silver reduction and nanoparticle stabilization. The synthesized AgNPs presented a spherical or polygonal morphology shape by TEM analysis and AgNPs showed high levels of antioxidant and considerable antibacterial and antifungal activities. Synthesized nanoparticles presented significant antioxidant activity by sequestration of DPPH and ABTS radicals, in addition to iron reduction (FRAP assay) and measurement of antioxidant capacity in ORAC units, in addition, AgNP synthesized with the aqueous fraction also demonstrated antioxidant potential in microglial cells. Gram-positive and Gram-negative bacteria were susceptible to growth inhibition by the nanoparticles, among which the AgNPs formed by the ethanolic extract was the most effective. The data obtained by AFM images suggested that AgNPs could lead to the lysis of bacteria and subsequent death. The antifungal assays showed high efficiency against yeasts and dermatophytes. This work represents the first description of antifungal activity by AgNPs against Fonsecaea pedrosoi, the etiologic agent of chromoblastomycosis. In relation to biocompatibility, the AgNPs induced lower haemolysis than AgNO3.We thank Herbert Kogler and Reinhard Wimmer for the identification of Eschweilenol C. The NMR laboratory at Aalborg University is supported by the Obel Family, SparNord and Carlsberg foundations.The authors are grateful to Carla Eiras (LIMAV/CT/UFPI) and to FCT and EU for financial support through project UID/QUI/50006/2013– POCI-01-0145-FEDER-007265 from COMPETE and projectNORTE-01-0145-FEDER-000011 from COMPETE. Thanks to Andreia Pinto for help with the TEM measurements at Instituto de Medicina Molecular (IMM). This work was supported by the Histology and Comparative Pathology Laboratory of the IMMinfo:eu-repo/semantics/publishedVersio

Nanoemulsões de anfotericina B e itraconazol : avaliação da atividade antifúngica in vitro e in vivo em agentes da cromoblastomicose

Cromoblastomicose é uma micose crônica que acomete a pele e o tecido subcutâneo. Vários tratamentos têm sido utilizados, mas a eficácia é extremamente baixa, não permitindo eleger uma terapia de escolha. No presente trabalho foram realizados: I – ensaios de suscetibilidade in vitro de agentes da cromoblastomicose contra antifúngicos comerciais; II - caracterização molecular de amostras oriundas de casos clínicos, bem como a descrição destes casos; III - a produção e caracterização de duas nanoemulsões, uma de anfotericina B e uma de itraconazol produzidas pela técnica de homogeneização à alta pressão; IV - a avaliação da atividade antifúngica destas nanoemulsões in vitro e in vivo em agentes da cromoblastomicose; V - a verificação do nível de comprometimento renal e hepático causados pelas nanoemulsões; VI - a avaliação da toxicidade das formulações produzidas. De modo geral, os agentes da cromoblastomicose, apresentaram maior suscetibilidade à terbinafina e ao itraconazol, respectivamente. A combinação de anfotericina B e terbinafina foi sinérgica para quatro dos cinco grupos avaliados. Quanto aos casos clínicos, no primeiro foi identificada uma infecção por E. spinifera e no segundo uma por Fonsecaea monophora. As nanoemulsões foram elaboradas com composição passível de administração parenteral, uma de anfotericina B e uma de itraconazol, pelo método de homogeneização à alta pressão. Não foi possível determinar as CIMs da nanoemulsão de anfotericina B e Abelcet® in vitro, enquanto que a nanoemulsão de itraconazol apresentou CIMs muito semelhantes às do fármaco livre. Em modelo animal de cromoblastomicose, a nanoemulsão de anfotericina B foi mais ativa que o fármaco livre, Fungizone® e Abelcet®. A nanoemulsão de itraconazol também apresentou melhor atividade quando comparada com o fármaco livre. Os níveis de uréia foram mais elevados nos animais que receberam anfotericina B livre e Fungizone®. A enzima alanina aminotransferase foi encontrada em níveis menores nos animais tratados com a nanoemulsão de itraconazol do que naqueles que receberam itraconazol livre. A anfotericina B livre e Fungizone® causaram graves danos aos rins. Nos animais tratados com Abelcet® e com a nanoemulsão de anfotericina B foi possível verificar apenas necrose focal. Da mesma forma, a nanoemulsão de itraconazol protegeu os animais contra danos hepáticos quando comparada com o fármaco livre. Em relação aos ensaios de toxicidade, a anfotericina B foi citotóxica em concentrações a partir de 4μg/mL, sendo que com a nanoemulsão esta toxicidade não foi observada em concentrações mais elevadas. O itraconazol foi citotóxico, sendo que este efeito não foi visto com a nanoemulsão. É de extrema importância a avaliação da suscetibilidade dos agentes da cromoblastomicose a fim de orientar a clínica. A identificação molecular de agentes isolados de casos clínicos pode contribuir para delinear o perfil epidemiológico da doença. As nanoemulsões de anfotericina B e itraconazol apresentaram atividades superiores in vivo quando comparadas aos demais tratamentos e foram capazes de reduzir os efeitos adversos causados por estes antifúngicos. Através de ensaios in vitro foi confirmada a redução da citotoxidade do fármaco quando veiculado na nanoemulsão. Assim, as nanoemulsões produzidas poderiam ser alternativas terapêuticas para o tratamento da cromoblatomicose.Chromoblastomycosis is a chronic mycosis that affects the skin and subcutaneous tissue. Various treatments have been used, but the efficacy is extremely low and does not allow choosing a therapy of choice. In the present work was performed: I - in vitro susceptibility testing for chromoblastomycosis agents against commercial antifungal; II - molecular characterization of samples from clinical cases as well as the description of these cases III - production and characterization of two nanoemulsions , one of amphotericin B and one of itraconazole, produced by high pressure homogenization technique; IV - assessing the in vitro and in vivo antifungal activity of these nanoemulsions against chromoblastomycosis agents; V - checking the level of impairment caused in the kidney and liver by nanoemulsions; VI - evaluation of toxicity of the formulations produced. In general, the chromoblastomycosis agents showed greater susceptibility to terbinafine and to itraconazole, respectively. The combination of amphotericin B and terbinafine was synergistic to four of the five groups. As for clinical cases, in the first was identified an infection by E. spinifera and in the second one by Fonsecaea monophora. The nanoemulsions were prepared with composition amenable of parenteral administration, one of amphotericin B and one of itraconazole, by the at high pressure homogenization method. Could not be determined the MIC of amphotericin B nanoemulsion and Abelcet® in vitro, while the itraconazole nanoemulsion showed MICs very similar to free drug. In a chromoblastomycosis animal model, the amphotericin B nanoemulsion was more active than free drug, Abelcet® and Fungizone®. The nanoemulsion of itraconazole also showed better activity compared to the free drug. Urea levels were higher in the animals receiving amphotericin B free and Fungizone®. The enzyme alanine aminotransferase was found in lower levels in animals treated with itraconazole nanoemulsion than in those who received itraconazole free. Amphotericin B free and Fungizone® caused severe damage to the kidneys. Already in animals treated with Abelcet® and the amphotericin B nanoemulsion was verified only focal necrosis. Likewise, the itraconazole nanoemulsion protected against liver damage when compared with the free drug. Regarding toxicity assays, amphotericin B was cytotoxic at concentrations from 4 μg/mL, while with the nanoemulsion this toxicity was not observed at higher concentrations. Itraconazole was cytotoxic, and this effect was not observed with the nanoemulsion. It is extremely important to evaluate the susceptibility of chromoblastomycosis agents to guide the clinic. Molecular identification of agents isolated from clinical cases can contribute to outline an epidemiological profile of the disease. The amphotericin B and itraconazole nanoemulsions showed higher activities in vivo when compared to other treatments and were able to reduce the adverse effects caused by these antifungals. Through in vitro assays were confirmed the reduction of the cytotoxicity of the drug when vehiculated in the nanoemulsion. Therefore, the nanoemulsions may be produced therapeutic alternatives for the chromoblastomycosis treatment